Overview
Adnan Aydiner practices in Istanbul, Turkey. Mr. Aydiner is rated as an Experienced expert by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Kaposi Sarcoma, and Mastectomy.
His clinical research consists of co-authoring 83 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Metastatic Brain Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerMr. Aydiner isAdvanced. Learn about Breast Cancer.
- Kaposi SarcomaMr. Aydiner isAdvanced. Learn about Kaposi Sarcoma.
- Lung CancerMr. Aydiner isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Aydiner isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Experienced
- Adult Soft Tissue SarcomaMr. Aydiner isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Brain TumorMr. Aydiner isExperienced. Learn about Brain Tumor.
- BRCA Positive Breast CancerMr. Aydiner isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenMr. Aydiner isExperienced. Learn about Breast Cancer in Men.
- EGFR Positive Lung CancerMr. Aydiner isExperienced. Learn about EGFR Positive Lung Cancer.
- HER-2 Positive Breast CancerMr. Aydiner isExperienced. Learn about HER-2 Positive Breast Cancer.